These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12191615)

  • 1. Integrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties.
    Yoganathan N; Yee A; Zhang Z; Leung D; Yan J; Fazli L; Kojic DL; Costello PC; Jabali M; Dedhar S; Sanghera J
    Pharmacol Ther; 2002; 93(2-3):233-42. PubMed ID: 12191615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin-linked kinase (ILK): a "hot" therapeutic target.
    Yoganathan TN; Costello P; Chen X; Jabali M; Yan J; Leung D; Zhang Z; Yee A; Dedhar S; Sanghera J
    Biochem Pharmacol; 2000 Oct; 60(8):1115-9. PubMed ID: 11007949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of integrin-linked kinase (ILK) in cancer progression.
    Persad S; Dedhar S
    Cancer Metastasis Rev; 2003 Dec; 22(4):375-84. PubMed ID: 12884912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
    White DE; Cardiff RD; Dedhar S; Muller WJ
    Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin-linked kinase: a cancer therapeutic target unique among its ILK.
    Hannigan G; Troussard AA; Dedhar S
    Nat Rev Cancer; 2005 Jan; 5(1):51-63. PubMed ID: 15630415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
    Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma.
    Rosanò L; Spinella F; Di Castro V; Dedhar S; Nicotra MR; Natali PG; Bagnato A
    Mol Cancer Ther; 2006 Apr; 5(4):833-42. PubMed ID: 16648553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
    Oloumi A; Syam S; Dedhar S
    Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity.
    Cordes N
    Cancer Res; 2004 Aug; 64(16):5683-92. PubMed ID: 15313908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The integrin-linked kinase (ILK) suppresses anoikis.
    Attwell S; Roskelley C; Dedhar S
    Oncogene; 2000 Aug; 19(33):3811-5. PubMed ID: 10949937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin-linked kinase and PINCH: partners in regulation of cell-extracellular matrix interaction and signal transduction.
    Wu C
    J Cell Sci; 1999 Dec; 112 ( Pt 24)():4485-9. PubMed ID: 10574698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ILKAP regulates ILK signaling and inhibits anchorage-independent growth.
    Kumar AS; Naruszewicz I; Wang P; Leung-Hagesteijn C; Hannigan GE
    Oncogene; 2004 Apr; 23(19):3454-61. PubMed ID: 14990992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer.
    Mongroo PS; Johnstone CN; Naruszewicz I; Leung-Hagesteijn C; Sung RK; Carnio L; Rustgi AK; Hannigan GE
    Oncogene; 2004 Nov; 23(55):8959-70. PubMed ID: 15467740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling.
    Dedhar S; Williams B; Hannigan G
    Trends Cell Biol; 1999 Aug; 9(8):319-23. PubMed ID: 10407411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
    Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
    Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells.
    Chou CC; Chuang HC; Salunke SB; Kulp SK; Chen CS
    Oncotarget; 2015 Apr; 6(10):8271-85. PubMed ID: 25821081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling.
    Qian Y; Zhong X; Flynn DC; Zheng JZ; Qiao M; Wu C; Dedhar S; Shi X; Jiang BH
    Oncogene; 2005 Apr; 24(19):3154-65. PubMed ID: 15735674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of integrin-linked kinase signalling in sporadic human colon cancer.
    Marotta A; Parhar K; Owen D; Dedhar S; Salh B
    Br J Cancer; 2003 Jun; 88(11):1755-62. PubMed ID: 12771992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetraspanin 8 is a novel regulator of ILK-driven β1 integrin adhesion and signaling in invasive melanoma cells.
    El Kharbili M; Robert C; Witkowski T; Danty-Berger E; Barbollat-Boutrand L; Masse I; Gadot N; de la Fouchardière A; McDonald PC; Dedhar S; Le Naour F; Degoul F; Berthier-Vergnes O
    Oncotarget; 2017 Mar; 8(10):17140-17155. PubMed ID: 28188308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin linked kinase (ILK) expression and function in vascular smooth muscle cells.
    Ho B; Bendeck MP
    Cell Adh Migr; 2009; 3(2):174-6. PubMed ID: 19262169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.